2Carvajal K, Moreno-Sanchez R. Heart metabolic disturbances in cardiovascular diseases[J]. Arch Med Res, 2003,34 (2): 89-99.
3Pauly DF, Pepine CJ. The role of carnitine in myocardial dysfunction[J]. Am J Kindey Dis,2003,41(suppl 4):s35-38.
4Hoppel C. The role of carnitine in normal and altered fatty acid metabolism[J]. Am J Kindey Dis, 2003,41(Suppl 4) : s4-12.
5Ferrari R,Merli E,Cicchitelli G,et al. Therapeutic effects of L- carnitine and propionyl -L-carnitine on cardiovascular diseases:review [J]. Ann N Y Acad Sci,2004,1003:79-91.
6Colonna P, Iliceto S. Myocardial infarction and left ventricular re-modeling: result of the CEDIM trial[J]. Am Heart J, 2000, 139(2 Pt 3):s124-130.
1IRAT A M, AKTAN F, OZANSOY G. Effects of L-carnitine treatment on oxidant/antioxidant state and vascular reactivity of streptozotocin-diabetic rat aorta[J]. J Pharm Pharmacol,2003, 55(10) :1389-1395.
2GURLEK A, TUTAR E, AKCIL E, et al . The effects of Lcarnitine treatment on left ventricular function and erythrocyte superoxide dismutase activity in patients with ischemic cardiomyopathy[J]. Eur J Heart Fail, 2000, 2(2):189-193.
3LOSTER H, BOHM U. L-carnitine reduces malondialdehyde concentrations in isolated rat hearts in dependence on perfusion conditions[J]. Mol Cell Biochem, 2001, 217(1-2):83-90.
4TATLICAN O, KALAYCIOGLU S, GOKGOZ L, et al. The dose-dependent effects of L-carnitine in myocardial protection in normothermic ischemia[J]. Cardiovasc Surg, 1998, 6(2):145-148.
5CARVAJAL K, MORENO-SANCHEZ R. Heart metabolic disturbances in cardiovascular diseases [J]. Arch Med Res,2003, 34(2) :89-99.
6CALVANI M, REDA E, ARRIGONI-MARTELLI E.Regulation by carnitine of myocardial fatty acid and carbohydrate metabolism under normal and pathological conditions[J]. Basic Res Cardiol, 2000, 95(2):75-83.
7KANTOR P F, DYCK J R, LOPASCHUK G D. Fatty acid oxidation in the reperfused ischemic heart[J]. Am J Med Sci,1999, 318 (1):3-14.
8SAKAMOTO T, AOKI M, IMAI Y, et al . Carnitine affects fatty acid metabolism after cardioplegic arrest in neonatal rabbit hearts[J]. Ann Thorac Surg, 2001, 71(2):648-653.
9De GAETANO A, MINGRONE G, CASTAGNETO M, et al. Carnitine increases glucose disposal in humans[J]. J Am Coll Nutr, 1999, 18(4) :289-295.
10NEMOTO S, AOKI M, DEHUA C, et al. Effects of carnitine on cardiac function after cardioplegic ischemia in neonatal rabbit hearts[J]. Ann Thorac Surg, 2001, 71 (1):254-259.
3Dorshow JH.Doxorubicin-induced cardiac toxicity[J].N Eng Med,1991,324(12):843.
4Singal,Pawan K Iliskovic,Natasha.Doxorubicin-induced cardiomyopathy[J].N Eng Med,1998,339(13):990-905.
5Nakamura,Tsuneyuki MD Ueda,Yoshimichi MD,et al.Fasmediated apoptosis in adriamycin-induced cardiomyopathy in rots:in vivo study[J].Circulation,2000,102(5):572-578.
